Smith Group Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Smith Group Asset Management's EW Position: Q3 2020 in Review
Smith Group Asset Management sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 318,638 shares — an estimated $22M sold.
Smith Group Asset Management first reported a position in EW in Q2 2014 and held it in 17 quarters. The position peaked at $54.5M in Q3 2016. 1,084 funds tracked by Wall St. Rank hold EW as of Q3 2020.
- Smith Group Asset Management reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
- Smith Group Asset Management sold 318,638 Edwards Lifesciences shares in Q3 2020, an estimated $22M.
- Smith Group Asset Management first reported a position in Edwards Lifesciences in Q2 2014 and held it in 17 quarters.
- Smith Group Asset Management's Edwards Lifesciences position peaked at $54.5M in Q3 2016.
- 1,084 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.
Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.